Tags: Ebola Outbreak | ebola | ervebo | fda | africa

FDA Approves Ebola Vaccine Ervebo

health workers at an ebola treatment center in beni, congo drc
Health workers at an Ebola treatment center in Beni, Congo DRC. (Jerome Delay/AP)

Friday, 20 December 2019 07:24 AM

The U.S. Food and Drug Administration said on Thursday it approved drugmaker Merck & Co's Ebola vaccine Ervebo, making it the first FDA-authorized vaccine against the deadly virus.

The vaccine was used by the World Health Organization and the Democratic Republic of the Congo as an investigational vaccine to help reduce Ebola virus disease (EVD) outbreaks in West African countries from 2014 to 2016.

The Ebola virus, which causes haemorrhagic fever and spreads from person to person through direct contact with body fluids, has killed more than 2,100 people in Congo since the middle of the year, making it the second-largest Ebola outbreak in history.

The vaccine, which is administered as a single-dose injection, will help to prevent EVD caused by Zaire ebolavirus in patients aged 18 years and older, the regulator said in a statement.

Merck welcomed the FDA's decision, describing it as an important milestone in the fight against the deadly virus.

In November, Merck received approval from the European Commission to market Ervebo, less than a month after a European medicines panel backed the first-ever vaccine against the virus.

© 2020 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
Newsfront
The U.S. Food and Drug Administration said on Thursday it approved drugmaker Merck & Co's Ebola vaccine Ervebo, making it the first FDA-authorized vaccine against the deadly virus.
ebola, ervebo, fda, africa
182
2019-24-20
Friday, 20 December 2019 07:24 AM
Newsmax Media, Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved